NCT03686722View on ClinicalTrials.gov

Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 9, 2017

Primary Completion Date

October 30, 2017

Study Completion Date

December 6, 2017

Conditions
Diabetes Mellitus, Type 2Hepatitis CDrug Interactions
Interventions
DRUG

Metformin

Metformin is used primarly in treatment of diabetes type II

DRUG

Daclatasvir

Daclatsvir is a direct acting antiviral drug

Trial Locations (1)

Unknown

Drug research centre, Cairo

All Listed Sponsors
collaborator

Ain Shams University

OTHER

collaborator

Drug Research Centre, Cairo, Egypt

OTHER

lead

Mohamed Raslan

OTHER

NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin | Biotech Hunter | Biotech Hunter